CytoPherx

Treatment of inflammation-based diseases and conditions using selective cytopheresis system
(Formerly Nephrion)
(2008)
Location:
Ann Arbor, MI
Management:
Jim Danehy, CEO; David Humes, CSO
UM Inventor(s):
H. David Humes
Funding parties:
Apjohn Ventures, Diamond Capital Management, Lurie Investments Inc., North Coast Technology Investors LP, Western Michigan University